Dr. Nastiuk is a researcher primarily focused on growth control of prostate cancer and prostatic disease. He earned a BA with high honors from Oberlin College. His graduate training was at The Rockefeller University in the Laboratory of Animal Behavior. Dr. Nastiuk then undertook fellowship training in the Nobel lab of Paul Greengard on the biochemistry of signaling and protein translation control, followed by further training with Dr. John Krolewski on signaling mechanisms controlling prostate cancer. Following appointment as a research scientist in the department of Pathology at UC Irvine, Dr. Nastiuk moved to the University of Rochester in 2012.
Patient Care Bio
Genetic sequence variation influences a variety of disease development and phenotype. Sequencing technologies, ranging from single gene, to high throughput (so called "Next Generation Sequecing") allows us to identify the genetic variation underlying cancers (onco-genomics) as well as genetics (from developmental defects to drug metabolism). Dr. Nastiuk is interested in the technology in developing and implementing genetic testing.